The benchmark STOXX index was on track for its fourth consecutive session of record gains, as well as a sixth straight weekly rise, its longest such streak since March 2024.

A credit card enthusiast and avid traveler, Lori has visited more than 60 countries, many of them using credit card points and frequent flyer miles. She has lived in Spain as a freelance writer ...

Overview: Alliant, an online credit union, has solid rates across its share certificates with terms ranging from three months to five years. The minimum deposit of $1,000 is somewhat low.

Biogen’s applications for the higher dose regimen of SMA drug Spinraza are now under review in the US and Europe.

He has been quoted by publications l... Clint ProctorLead Editor, Credit Cards & Travel Rewards Clint Proctor is a lead editor with the credit cards and travel rewards team at Forbes Advisor.

Novartis AG’s plan to sell its 70.6% stake in Novartis India is on track, CEO Vas Narasimhan confirmed at the World Economic Forum in Davos. Speaking to CNBC-TV18, he emphasised the company’s ...

Matt is currently Head of the Coverage Team at The Motley Fool. He has been a full-time Motley Fool employee since 2012 and is a former advisor and analyst for multiple Motley Fool services.

Greece on Monday prosecuted a pair of protected witnesses for alleged perjury in a long-running bribery probe involving the Swiss pharmaceutical firm Novartis, a justice source said. The man and woman ...

Novartis won an order from a U.S. appeals court in Washington on Thursday temporarily blocking MSN Pharmaceuticals from launching a generic version of Novartis' heart-failure drug Entresto, per a ...

TIN-816 is under clinical development by Novartis and currently in Phase II for Sepsis. According to GlobalData, Phase II drugs for Sepsis have a 50% phase transition success rate (PTSR) indication ...